Mr. Truckenmiller joined the company in July 2016 as vice president, Market Access & Customer Solutions, where he implemented new processes and procedures to optimize development and operations of all EMD Serono contracted business.
Previously, Mr. Truckenmiller served as vice president and head of U.S. Market Access & Pricing at UCB, where he led a large team in developing a market access strategy that successfully improved overall patient access to UCB brands. He spent eleven years at UCB, taking on roles of increasing responsibility across market access and brand marketing. Additionally, he has more than 15 years of experience in the biopharmaceutical industry in various sales and marketing roles at companies such as Johnson & Johnson and DaVita Kidney Care.
"Rob has demonstrated tremendous knowledge of the payer landscape, offering strategic insights and creating processes to ensure patients receive the medications they need," said Gary Zieziula, President and Managing Director of EMD Serono. "With his strong track record, I know Rob will successfully lead EMD Serono in delivering meaningful therapies to people with difficult to treat diseases."